Oxford Centre for Haematology
The Oxford Centre for Haematology aims to bring together doctors, researchers, nurses and allied health professionals to help improve the care of patients with blood diseases.
As one of the themes within the NIHR Oxford Biomedical Research Centre, we strive to push the frontiers of scientific research and translate new discoveries into better diagnosis and new treatments for patients with blood diseases.
Our research themes
Latest News and Publications
Transitions in lineage specification and gene regulatory networks in hematopoietic stem/progenitor cells over human development.
Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.
Single-cell profiling of human bone marrow progenitors reveals mechanisms of failing erythropoiesis in Diamond-Blackfan anemia.
Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology.
Multiple Cereblon genetic changes associate with acquired resistance to Lenalidomide or Pomalidomide in Multiple Myeloma.
Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia.
Non-invasive diagnosis of deep vein thrombosis from ultrasound imaging with machine learning.
T cell Immunotherapy animation launched
26 January 2023
A new animation explores work by the Chakraverty Group, Vyas Group, and Professor Borrow from the Jenner Institute.
Patient priorities guide Oxford Myeloma research
29 March 2022
Medical staff in Oxford are partnering closely with Myeloma patients to help set priorities for future research.
Spin-out company Alethiomics launches
15 December 2021
The enterprise will focus on developing targeted therapies for a specific family of blood cancers.
Interview with Excellence Award winner Dr Susan Shapiro
9 December 2021
A member of the Oxford Centre For Haematology, Dr Shapiro, was recently interviewed by the Royal College of Pathologists.
HAEMATOLOGY IN OXFORD
OCH is a virtual centre, with members spread out over the University of Oxford and OU Hospital sites. Our hub is based at the MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, OX3 9DU.